SAN FRANCISCO, May 9, 2019 /PRNewswire/ — Today at the 40th annual Heart Rhythm Scientific Sessions, Acutus Medical announced the agreement to acquire Rhythm Xience, Inc., and new strategic partnerships with Peerbridge Health, Cardiac Designs and MedFact. Acutus’ expanded portfolio builds on the organization’s unprecedented mapping and visualization technology platform. Acutus is committed to helping […]
Rhythm
Stereotaxis and Osypka Enter Strategic Collaboration to Advance Robotic Catheter Technology
Development of next generation robotically-navigated magnetic ablation catheter fully owned by Stereotaxis Catheter designed to enhance patient care, improve therapy delivery, simplify catheter navigation, and strengthen commitment to open ecosystem Entered into additional business agreements to support a long-term broad collaboration in electrophysiology ST. LOUIS and RHEINFELDEN, Germany, May 09, […]
BIOSENSE WEBSTER ANNOUNCES INITIAL RESULTS FROM FIRST IN-HUMAN STUDY OF NOVEL HIGH POWER-SHORT DURATION ABLATION CATHETER FOR ATRIAL FIBRILLATION
Researchers Report QDOT MICRO Radiofrequency Ablation Catheter Demonstrates Safety and Achieves Pulmonary Vein Isolation with Shorter Procedure and Fluoroscopy Times SAN FRANCISCO — May 9, 2019 – Johnson & Johnson Medical Devices Companies* today announced that Biosense Webster, Inc.’s QDOT MICRO, a novel catheter that facilitates high power-short duration radiofrequency […]
Murj Announces the Future of Cardiac Device Analytics
SANTA CRUZ, Calif., May 08, 2019 (GLOBE NEWSWIRE) — Murj, the digital healthcare company for Software-as-a-Service (SaaS) cardiac implantable electronic device (CIED) management announced today the availability of Murj Analytics. This new offering features powerful intelligence for cardiac device clinicians seeking to provide comprehensive population management through improved clinical, workforce […]
BioCardia Receives FDA Clearance for AVANCE Steerable Introducer for Transseptal Access to Heart
SAN CARLOS, Calif., May 08, 2019 (GLOBE NEWSWIRE) — BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the AVANCE™ steerable introducer product family, designed for introducing various cardiovascular catheters into the heart, including […]
Study Finds Micro-AF is a Predictor of Clinical AF, Provides Guidance on ECG Monitoring Duration
PLANO, Texas, May 8, 2019 /PRNewswire/ — MediLynx Cardiac Monitoring, LLC today announced new research connecting short episodes of Atrial Fibrillation called micro-AF (4 beats <29) with the presentation of clinical AF (>30 seconds). The study showed that 83% of patients with micro-AF also had a clinical AF episode during prolonged registration, and […]
Preventice Solutions Presents Real-World Performance of Wearable ECG Monitoring Technology using Deep Learning Algorithms for Detecting Atrial Fibrillation
MINNEAPOLIS, May 8, 2019 /PRNewswire/ — At Heart Rhythm 2019, the Heart Rhythm Society’s 40th Annual Scientific Sessions, Preventice Solutions will present clinical data validating its BodyGuardian® Remote Monitoring System with the BeatLogic™ deep learning platform. This technology leverages machine learning and artificial intelligence (AI) for detection of atrial fibrillation (AF) and was validated using […]
Impulse Dynamics Announces Successful Implantation of First Patient Since FDA Approval of Optimizer® Smart System
NEW YORK, May 8, 2019 /PRNewswire/ — Impulse Dynamics, developer of the implantable Optimizer® Smart System for delivering CCM™ therapy, announced today that the first patient to receive the Optimizer Smart System since the device was approved by the U.S. Food and Drug Administration was successfully implanted. The procedure, which occurred on Monday, May […]
BioTrace Medical’s Tempo Lead Obtains CE Mark for Safe and Secure Temporary Intracardiac Pacing
MENLO PARK, Calif.–(BUSINESS WIRE)–BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s Tempo® Lead has obtained CE Mark certification in Europe for use in cardiac procedures requiring temporary intracardiac pacing. BioTrace Medical’s Tempo Temporary Pacing Lead is designed for safer, more secure and stable pacing to […]
FARAPULSE Receives FDA Breakthrough Designation for its Endocardial Pulsed Field Ablation System
MENLO PARK, CA, May 8, 2019 /PRNewswire/ – FARAPULSE Inc. (“FARAPULSE” or “the “Company”) today announced it has received Breakthrough Device designation from the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) for its Endocardial Ablation System. The system is being developed to advance the […]



